This measure identifies patients with diabetes mellitus taking insulin that had evidence of self-monitoring blood glucose testing in last 12 reported months.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Did the patient fill a prescription for any of the following during the following time period: last 12 months of the report period through 90 days after the end of the report period?
? Glucometers (RX-175)
? Blood Glucose Test Strips (RX-176)
Time Window: 12 months prior to the end of the report period through 90 days after the end of the report period
-
1.15 Denominator
Adults with diabetes who are taking insulin as defined below:
Time Window:
1. The 24 months prior to the end of the report period is used to identify patients with diabetes.
2. The last 120 days of the report period through 90 days after the end of the report period is used to identify insulin using population
-
Exclusions
1. Absence of a prescription for Insulin (code set RX-59) during the following time period: last 120 days of the report period through 90 days after the end of the report period?
2. During the 12 months prior to the end of the report period, did the patient have 1 or more of the following services or events, where the diagnosis was Polycystic Ovaries (code set DX0312), Gestational Diabetes (DX0313), or Steroid-induced Diabetes (DX0314):
? Professional Encounter Code Set (code set PR0107, RV0107)
? Professional Supervision (code set PR0108)
? Facility Event – Confinement/Admission
? Facility Event – Emergency Room
? Facility Event – Outpatient Surgery
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Endocrine Endorsement Maintenance ProjectInitial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)
-